Polarity of immunogens: implications for vaccine design
✍ Scribed by José Golvano; Juan J. Lasarte; Pablo Sarobe; Arturo Gullón; Jesús Prieto; Francisco Borrás-Cuesta
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 428 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In spite of 25 years of intensive research, no effective human immunodeficiency virus type 1 (HIV‐1) vaccine has yet been developed. One reason for this is that investigators have concentrated mainly on the structural analysis of HIV‐1 antigens because they assumed that it should be pos
Peptide epitopes for tumor-reactive cytotoxic T-lymphocytes (CTL) have been identified on human cancers and are being used in tumor vaccine trials. However, the pharmacokinetics and pharmacodynamics of such peptides have been inadequately studied. It is predicted that immunogenic tumor peptides woul